EIVIX | VIVIX | EIVIX / VIVIX | |
Total Expense Ratio | 0.50 | 0.04 | 1,250% |
Annual Report Gross Expense Ratio | 0.56 | 0.04 | 1,400% |
Fund Existence | 19 years | 27 years | - |
Gain YTD | 8.839 | 5.154 | 171% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2B | 196B | 1% |
Annual Yield % from dividends | 0.90 | 2.19 | 41% |
Returns for 1 year | 4.29 | 9.02 | 48% |
Returns for 3 years | 21.03 | 25.01 | 84% |
Returns for 5 years | 26.77 | 65.45 | 41% |
Returns for 10 years | 14.08 | 112.16 | 13% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTAX | 28.65 | N/A | N/A |
Fidelity Advisor Biotechnology A | |||
FRIQX | 12.08 | N/A | N/A |
Fidelity Advisor Real Estate Income M | |||
TGVVX | 61.49 | N/A | N/A |
Touchstone Dynamic Large Cap Growth I | |||
PFISX | 12.32 | N/A | N/A |
Principal International Small Company R6 | |||
VKSFX | 10.45 | N/A | N/A |
Virtus KAR Small-Mid Cap Value I |